SARASOTA — Pharmaceutical executive David Zaccardelli has joined the Sarasota Architectural Foundation board of directors.
According to a press release, Zaccardelli has served in several senior management roles, including acting CEO of Cempra Pharmaceuticals and chief operating officer, chief manufacturing officer and executive vice president of United Therapeutics Corp.
He also founded and led a startup focused on contract pharmaceutical development services. Zaccardelli serves on the board of directors of Melinta Therapeutics, Evecxia Inc. and CoreRx Inc.
"Dave brings both depth and breadth of expertise from his fruitful career
accomplishments to our nonprofit organization," says Anne Marie Bergevin, co-chair of the SAF board, in a statement.
SAF's mission is to educate, advocate and celebrate the legacy of the Sarasota School of Architecture.